Clinical Trial Update: A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adalimumab introduction versus methotrexate dose escalation in psoriatic arthritis; study completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2020-11-23